Hormone imbalances detected in study participants with pre-diabetes in a Durban-based clinical setting, South Africa

Background Type II diabetes mellitus onset is linked with hormonal imbalances. However, the knowledge about hormonal alterations in pre-diabetes is limited. Objective The study aimed to examine type II diabetes mellitus-associated hormone levels during the pre-diabetes phase in participants aged 25–...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:International journal of diabetes in developing countries Ročník 45; číslo 2; s. 416 - 423
Hlavní autoři: Sosibo, Aubrey M., Mzimela, Nomusa C., Ngubane, Phikelelani S., Khathi, Andile
Médium: Journal Article
Jazyk:angličtina
Vydáno: New Delhi Springer India 01.06.2025
Springer Nature B.V
Témata:
ISSN:0973-3930, 1998-3832
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Background Type II diabetes mellitus onset is linked with hormonal imbalances. However, the knowledge about hormonal alterations in pre-diabetes is limited. Objective The study aimed to examine type II diabetes mellitus-associated hormone levels during the pre-diabetes phase in participants aged 25–45 in a Durban-based clinical setting in South Africa. Methods Stored plasma samples from a retrospective study collected 364 samples that were divided into pre-diabetes and non-pre-diabetes groups. From the 364, 38 samples from the group of persons without pre-diabetes and 38 from persons with glycated haemoglobin determined pre-diabetes were blindly selected. The hormone concentrations (C-peptide, cortisol, adipokines, thyroids, incretins, and sex steroids) of the study participants were measured using the BIO-RAD Bio-Plex MAGPIX instrument. Results Hormone imbalances in several hormones were detected in study participants with pre-diabetes. Most of the hormone dysregulation associated with T2DM begins in pre-diabetes but at a moderate level. Conclusion The findings reveal new possible hormone therapy targets for pre-diabetes and contribute to the growing support for targeting pre-diabetes as a preventative measure for T2DM prevention.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0973-3930
1998-3832
DOI:10.1007/s13410-024-01363-z